ArticleCurrent cancer drug targets2025
TCF19 Enhances Glioma Cell Proliferation via Modulating the Β-Catenin Signaling Pathway through Accelerating DHX32 Transcription.
Jing Tan et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it